EC Number   |
Activating Compound |
Reference |
|---|
   3.4.21.22 | 1,2-dicaproyl-sn-glycero-3-phospho-L-serine |
up-regulates the catalytic activity of the enzyme |
732759 |
| 3.4.21.22 | 1,2-propanediol |
25-40% v/v, up to 20fold increase of the activity, methoxycarbonyl-D-Nle-Gly-Arg-p-nitroanilide as substrate, rFIXa |
95341 |
| 3.4.21.22 | 1,3-Propanediol |
affect the activity only to a slight extent |
95341 |
| 3.4.21.22 | 1,3-Propanediol |
affect the activity only to a slight extent, rFIXa |
95341 |
| 3.4.21.22 | 1,4-Butanediol |
affect the activity only to a slight extent, rFIXa |
95341 |
| 3.4.21.22 | anionic phospholipid |
highly activating |
683625 |
| 3.4.21.22 | cofactor VIIIa |
- |
691159 |
| 3.4.21.22 | diethylene glycol |
increases the activity 2fold |
95341 |
| 3.4.21.22 | emicizumab |
factorIXa/factorX bispecific antibody. Emicizumab functions as a cofactor to promote the factor IXa-catalyzed factor X activation |
753894 |
| 3.4.21.22 | enoxaparin |
in the presence of bovine pancreatic trypsin inhibitor |
667599 |
